ATX expression correlates inversely with miR‐101‐3p levels in cancer cells, which is consistent with previous reports that ATX is highly expressed and miR‐101 is downregulated in various cancers, such as neuroblastoma, breast cancer, hepatocellular carcinoma, and non‐small‐cell lung cancer. This evidence concerns the gene ENPP2 and hepatocellular carcinoma.